NCT04079686View on ClinicalTrials.gov

Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty

NACompletedINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

August 4, 2019

Primary Completion Date

October 28, 2024

Study Completion Date

October 28, 2024

Conditions
Plastic SurgeryMammaplastyAnti-bacterial AgentsProphylaxisWound Infection
Interventions
DRUG

Cephazolin

Patients undergoing reduction mammaplasty will receive 1g of cephazolin intravenously anesthetic induction and postoperatively every 6 hours, for 24 hours.

OTHER

Sterile saline

Patients undergoing reduction mammaplasty will receive 1g of cephazolin intravenously anesthetic induction and intravenous sterile saline postoperatively, every 6 hours, for 24 hours.

Trial Locations (1)

37550000

Hospital das Clinicas Samuel Libânio, Universidade do Vale do Sapucaí, Pouso Alegre

All Listed Sponsors
lead

Daniela Francescato Veiga

OTHER

NCT04079686 - Single Dose Versus 24 Hours Antibiotic Prophylaxis in Reduction Mammaplasty | Biotech Hunter | Biotech Hunter